Search results
Results from the WOW.Com Content Network
The effects of hormonal birth control on breast cancer risk have been studied for decades. Many studies over the years have shown that hormone-containing birth control options, specifically ...
A 2013 meta-analysis concluded that every use of birth control pills is associated with a modest increase in the risk of breast cancer (relative risk 1.08) and a reduced risk of colorectal cancer (relative risk 0.86) and endometrial cancer (relative risk 0.57).
Progestogen-only birth control is not generally associated with a higher risk of breast cancer. [70] Conversely, combined birth control and menopausal hormone therapy with an estrogen and a progestogen are associated with higher risks of breast cancer. [71] [70] [72]
A new study is offering more information for women about whether the type of birth control they take increases their risk of breast cancer more than another. The study, published Monday in PLOS ...
Combined hormonal contraception (CHC), or combined birth control, is a form of hormonal contraception which combines both an estrogen and a progestogen in varying formulations. [ 1 ] [ 2 ] The different types available include the pill , the patch and the vaginal ring , which are all widely available, [ 3 ] and an injection , which is available ...
Studies have suggested for decades that birth control pills containing both estrogen and progestogen — synthetic versions of female hormones — may slightly elevate one’s risk of breast cancer.
Ethinylestradiol sulfonate (EES), sold under the brand names Deposiston and Turisteron among others, is an estrogen medication which has been used in birth control pills for women and in the treatment of prostate cancer in men. [1] [5] [2] [3] [6] It has also been investigated in the treatment of breast cancer in women.
Studies on IUDs and cancer suggest a mix of pros and cons, similar to those associated with birth control pills: a slightly elevated risk of breast cancer, balanced by reductions in the risk of ...